The EMP3 gene has been proposed as a candidate tumor suppressor gene (TSG) on 19q13.3 in several human solid tumors, such as gliomas, neuroblastoma, esophageal squamous cell carcinoma (ESCC), breast cancer, and pheochromocytoma [5–12]. This evidence concerns the gene EMP3 and breast cancer.